You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/3OzdJqa90Pmu/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

Former Pfizer Employee Karen Kingston And Dr Robert Malone Are Both Correct

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 00:03 UTC on August 26th, 2021.

#rwmalonemd
#fda
#vaccines

BitChute.com/PLC - ???

PLC ✓ᵛᵉʳᶦᶠᶦᵉᵈ

subscribers

Your platform for uncensored ideas. BitChute Premium.

BitChute Advertisement

8-25-2021 What people are confused about is that the FDA approval did go through, and does not apply to the Pfizer Covid-19 Injections going around at the moment. The FDA has requirements, and upon meeting those requirements, there will be a name change, so that name change will identify the FDA approval product which will be liable for injuries and must reveal its ingredients.

Comirnaty (aka Pfizer)

FDA Pfizer authorization (Comirnaty): Key points to consider and discuss.
https://www.rwmalonemd.com/news/7ea84jm9hlt36rnk4g5ex5l5zwbtxt

View The FDA Letter Of Approval To Pfizer
https://www.fda.gov/media/151710/download

Page 5

1. Deferred pediatric Study C4591001 to evaluate the safety and effectiveness of
COMIRNATY in children 12 years through 15 years of age.

Final Protocol Submission: October 7, 2020

Study Completion: May 31, 2023

Final Report Submission: October 31, 2023

2. Deferred pediatric Study C4591007 to evaluate the safety and effectiveness of
COMIRNATY in infants and children 6 months to <12 years of age.

Final Protocol Submission: February 8, 2021

Study Completion: November 30, 2023

Final Report Submission: May 31, 2024

3. Deferred pediatric Study C4591023 to evaluate the safety and effectiveness of
COMIRNATY in infants <6 months of age.

Final Protocol Submission: January 31, 2022

Study Completion: July 31, 2024